• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜后肉瘤外科治疗的经济负担。

Financial burden of surgical treatment for retroperitoneal sarcoma.

机构信息

Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan.

Division of Gastroenterological Surgery, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

Surg Today. 2024 Oct;54(10):1201-1207. doi: 10.1007/s00595-024-02831-z. Epub 2024 Apr 12.

DOI:10.1007/s00595-024-02831-z
PMID:38607396
Abstract

PURPOSES

The purpose of this study was to compare the financial burden of surgery for retroperitoneal sarcoma (RPS) and gastric cancer (GC).

METHODS

All patients who underwent surgery for GC or RPS between 2020 and 2021 at Nagoya University Hospital were included. The clinical characteristics, surgical fees per surgeon, and surgical fees per hour were compared between the two groups.

RESULTS

The GC and RPS groups included 35 and 63 patients, respectively. In the latter group, 37 patients (59%) underwent tumor resection combined with organ resection; the most common organ was the intestine (n = 23, 37%), followed by the kidney (n = 16, 25%). The mean operative time (248 vs. 417 min, p < 0.001) and intraoperative blood loss (423 vs. 1123 ml, p < 0.001) were significantly greater in the RPS group than in the GC group. The mean surgical fee per surgeon was USD 1667 in the GC group and USD 1022 in the RPS group (p < 0.001) and USD 1388 and USD 777 per hour, respectively (p < 0.001).

CONCLUSIONS

The financial burden of surgical treatment for RPS is unexpectedly higher than that for GC.

摘要

目的

本研究旨在比较腹膜后肉瘤(RPS)和胃癌(GC)手术的经济负担。

方法

纳入 2020 年至 2021 年在名古屋大学医院接受 GC 或 RPS 手术的所有患者。比较两组患者的临床特征、每位外科医生的手术费用和每小时手术费用。

结果

GC 组和 RPS 组分别纳入 35 例和 63 例患者。在后一组中,37 例(59%)患者接受了肿瘤切除联合器官切除;最常见的器官是肠(n=23,37%),其次是肾脏(n=16,25%)。RPS 组的手术时间(248 分钟比 417 分钟,p<0.001)和术中出血量(423 毫升比 1123 毫升,p<0.001)明显大于 GC 组。GC 组每位外科医生的手术费用为 1667 美元,RPS 组为 1022 美元(p<0.001),每小时费用分别为 1388 美元和 777 美元(p<0.001)。

结论

RPS 手术治疗的经济负担出乎意料地高于 GC。

相似文献

1
Financial burden of surgical treatment for retroperitoneal sarcoma.腹膜后肉瘤外科治疗的经济负担。
Surg Today. 2024 Oct;54(10):1201-1207. doi: 10.1007/s00595-024-02831-z. Epub 2024 Apr 12.
2
Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.低容量医院的治疗与腹膜后肉瘤患者的短期和长期预后降低有关。
Cancer. 2018 Dec 1;124(23):4495-4503. doi: 10.1002/cncr.31699. Epub 2018 Oct 14.
3
Preoperative radiation for retroperitoneal sarcoma is not associated with increased early postoperative morbidity.术前放疗对腹膜后肉瘤并不增加术后早期的发病率。
J Surg Oncol. 2014 May;109(6):606-11. doi: 10.1002/jso.23534. Epub 2013 Dec 30.
4
Combined management of retroperitoneal sarcoma with dose intensification radiotherapy and resection: long-term results of a prospective trial.剂量强化放疗联合手术治疗腹膜后肉瘤:一项前瞻性试验的长期结果
Radiother Oncol. 2014 Jan;110(1):165-71. doi: 10.1016/j.radonc.2013.10.041. Epub 2014 Jan 7.
5
Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.腹膜后肉瘤初次扩大切除术后复发后的结局:跨大西洋腹膜后肉瘤工作组的报告
Cancer. 2017 Jun 1;123(11):1971-1978. doi: 10.1002/cncr.30572. Epub 2017 Feb 2.
6
Perioperative blood transfusion is not an independent predictor for worse outcomes in retroperitoneal sarcoma surgery.围手术期输血并不是腹膜后肉瘤手术预后不良的独立预测因素。
Eur J Surg Oncol. 2021 Jul;47(7):1763-1770. doi: 10.1016/j.ejso.2021.01.007. Epub 2021 Jan 13.
7
Postoperative Morbidity After Radical Resection of Primary Retroperitoneal Sarcoma: A Report From the Transatlantic RPS Working Group.原发性腹膜后肉瘤根治性切除术后的术后发病率:来自跨大西洋 RPS 工作组的报告。
Ann Surg. 2018 May;267(5):959-964. doi: 10.1097/SLA.0000000000002250.
8
Effect of intraoperative radiotherapy in the treatment of retroperitoneal sarcoma.术中放疗在腹膜后肉瘤治疗中的作用
Int J Clin Oncol. 2017 Jun;22(3):563-568. doi: 10.1007/s10147-016-1086-6. Epub 2017 Jan 10.
9
Unplanned reoperation after resection of retroperitoneal sarcoma: experience based on a high-volume sarcoma center.腹膜后肉瘤切除术后的计划性再手术:基于大容量肉瘤中心的经验。
World J Surg Oncol. 2022 May 18;20(1):158. doi: 10.1186/s12957-022-02633-y.
10
Effect of nephrectomy for retroperitoneal sarcoma on post-operative renal function.肾切除术治疗腹膜后肉瘤对术后肾功能的影响。
J Surg Oncol. 2018 Mar;117(3):425-429. doi: 10.1002/jso.24875. Epub 2017 Oct 16.

本文引用的文献

1
Primary retroperitoneal sarcoma: A comparison of survival outcomes in specialist and non-specialist sarcoma centres.原发性腹膜后肉瘤:在专业肉瘤中心和非专业肉瘤中心的生存结果比较。
Eur J Cancer. 2023 Jul;188:20-28. doi: 10.1016/j.ejca.2023.04.004. Epub 2023 Apr 17.
2
Two-step arterial reconstruction technique for en bloc resection of a large retroperitoneal liposarcoma involving the common iliac artery.两步式动脉重建技术在累及髂总动脉的巨大腹膜后脂肪肉瘤整块切除中的应用。
Surg Today. 2023 Nov;53(11):1320-1324. doi: 10.1007/s00595-023-02684-y. Epub 2023 Apr 20.
3
Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group.
成人局部复发性腹膜后肉瘤的治疗:来自跨大西洋澳大拉西亚腹膜后肉瘤工作组的最新共识方法。
Ann Surg Oncol. 2022 Nov;29(12):7335-7348. doi: 10.1245/s10434-022-11864-y. Epub 2022 Jun 29.
4
Precision guidelines for soft tissue and visceral sarcomas: the evidence, expert experience and ensuring optimal care for rare cancers, a 2021 update from ESMO-EURACAN-GENTURIS.软组织和内脏肉瘤的精准指南:证据、专家经验以及确保对罕见癌症的最佳治疗,ESMO-EURACAN-GENTURIS 2021年更新版
Ann Oncol. 2021 Nov;32(11):1325-1326. doi: 10.1016/j.annonc.2021.08.2155. Epub 2021 Sep 6.
5
Soft-tissue sarcoma in adults: An update on the current state of histiotype-specific management in an era of personalized medicine.成人软组织肉瘤:在个体化医学时代,组织亚型特异性管理的最新进展。
CA Cancer J Clin. 2020 May;70(3):200-229. doi: 10.3322/caac.21605. Epub 2020 Apr 10.
6
Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.低容量医院的治疗与腹膜后肉瘤患者的短期和长期预后降低有关。
Cancer. 2018 Dec 1;124(23):4495-4503. doi: 10.1002/cncr.31699. Epub 2018 Oct 14.
7
The Volume-Outcome Relationship in Retroperitoneal Soft Tissue Sarcoma: Evidence of Improved Short- and Long-Term Outcomes at High-Volume Institutions.腹膜后软组织肉瘤的体积-预后关系:高容量机构短期和长期预后改善的证据。
Sarcoma. 2018 Jul 24;2018:3056562. doi: 10.1155/2018/3056562. eCollection 2018.
8
Different quality of treatment in retroperitoneal sarcomas (RPS) according to hospital-case volume and surgeon-case volume: a retrospective regional analysis in Italy.根据医院病例数量和外科医生病例数量分析腹膜后肉瘤(RPS)的不同治疗质量:意大利的一项回顾性区域分析
Clin Sarcoma Res. 2018 Feb 28;8:3. doi: 10.1186/s13569-018-0091-0. eCollection 2018.